Case | Anti-viral | Immunosuppressive therapy | Follow-up time (months) | Scr (μmol/L) | eGFR (ml/min per 1.73m2) | 24hUP (g/d) | Cryocrit(%) | HBV-DNA (copies/ml) | Outcome |
---|---|---|---|---|---|---|---|---|---|
1 | ETV | CS + MMF | 37 | 90 | 67.00 | 0.80 | NA | < 103 | PR |
2 | ETV | CS + CYC + DFPP | 22 | 99 | 55.30 | 2.05 | 7.0 | < 103 | PR |
3 | ETV | CS + CYC + DFPP | 6 | 60 | 111.80 | 0.05 | 0 | < 103 | CR |
4 | LAM | CS + CYC | 3 | 119 | 54.13 | 3.77 | NA | NA | death |
5 | ETV | CS | 62 | 80 | 114.00 | 0.90 | 2.0 | 1.24 × 104 | PR |
6 | ETV | CS | 12 | 287 | 20.70 | 5.22 | NA | NA | death |
7 | ETV | CS + CYC | 18 | 900 | 5.50 | 9.92 | 0 | < 103 | dialysis |